Roughly 46 million Americans aged 12 and older met the criteria for a substance use disorder in the most recent comprehensive survey, representing about 16.5% of that population. That number includes alcohol, so the count for drug-specific disorders is smaller but still enormous: tens of millions of people struggling with opioids, stimulants, cannabis, or other substances. Here’s what the latest federal data shows.
What the Numbers Actually Measure
The term “drug addict” isn’t used in clinical settings anymore. Instead, healthcare providers diagnose substance use disorder, or SUD, based on 11 possible symptoms: taking a substance in larger amounts than intended, unsuccessful attempts to quit, spending excessive time obtaining or recovering from a drug, intense cravings, neglecting responsibilities, continued use despite relationship or health problems, giving up activities, using in dangerous situations, developing tolerance, and experiencing withdrawal. Meeting two or three of these criteria qualifies as a mild disorder. Six or more is classified as severe.
The federal government tracks these numbers through an annual household survey of about 70,000 people, run by the Substance Abuse and Mental Health Services Administration (SAMHSA). It’s the most comprehensive measure available, though it likely undercounts people who are homeless, incarcerated, or otherwise outside the survey’s reach.
Opioids: The Largest Crisis
In 2024, 7.8 million people aged 12 or older misused opioids in the past year, whether through heroin use or prescription painkiller misuse. That’s 2.7% of the population in that age group. Among those diagnosed with an opioid use disorder, 37.1% had a severe disorder, while 42.4% had a mild one.
Fentanyl has reshaped the opioid landscape. In 2024, 816,000 people used or misused some form of fentanyl, and 668,000 of those used illegally manufactured fentanyl rather than a prescription version. These numbers are almost certainly conservative, since many people who use street drugs containing fentanyl don’t realize it’s in their supply.
Stimulants: Methamphetamine and Cocaine
Methamphetamine use disorder affected 1.8 million people in 2023, about 0.6% of the population aged 12 and older. Cocaine use disorder affected 1.3 million, or 0.4%. These figures have been climbing steadily, and stimulant-related harms increasingly overlap with the opioid crisis.
That overlap matters. Nearly three-quarters of cocaine-involved overdose deaths in 2017 also involved an opioid. By 2020, about 40% of deaths involving illegally manufactured fentanyl also involved stimulants. People aren’t always using one substance in isolation, which makes the crisis harder to address and the death toll harder to attribute to any single drug.
The Treatment Gap
Of the 46 million Americans with a substance use disorder in 2021, only 6% received any form of treatment. That gap is staggering: for every person who got help, roughly 15 did not. Barriers include cost, lack of available programs, stigma, long wait times, and the simple fact that many people with a substance use disorder don’t believe they need treatment or aren’t ready to seek it.
Overdose Deaths
In 2024, 79,384 people died from drug overdoses in the United States, a rate of 23.1 deaths per 100,000 people. That number actually represents a decline from the peak of over 111,000 in 2022, largely due to wider availability of the overdose-reversal medication naloxone and shifts in drug supply patterns. Still, nearly 80,000 deaths in a single year means overdoses kill more Americans annually than car accidents.
The Economic Toll
The illicit opioid epidemic alone cost an estimated $2.7 trillion in 2023, equivalent to 9.7% of GDP. That figure, calculated by the White House, includes the economic value of lives lost, which accounts for the bulk of the total. The more tangible costs break down into several categories: $107 billion in additional healthcare expenses for people with opioid use disorder (about $19,000 extra per person per year compared to someone without the disorder), another $107 billion in lost workforce productivity from deaths, active addiction, and incarceration, and $63 billion in crime-related costs covering policing, courts, prisons, and property loss.
These figures cover only opioids. When you add methamphetamine, cocaine, and other substances, the full economic burden of drug addiction in the U.S. is substantially higher.